Rational design of a hybrid peptide against severe acute respiratory syndrome coronavirus 2 using melittin and angiotensin-converting enzyme 2 as pharmaceutical agents

Rational design of a hybrid peptide against severe acute respiratory syndrome coronavirus 2 using melittin and angiotensin-converting enzyme 2 as pharmaceutical agents

Background: Management of severe acute respiratory syndrome coronavirus 2 in humans depends on the availability of vaccines or effective drugs. Studies have shown that angiotensin-converting enzyme 2 (ACE2) is responsible for binding the viral spike glycoproteins to human cells. Melittin from the be...

Full description

Bibliographic Details
Main Authors: Ramin Farhoudi, Mohammad Taheri, Minoo Soltani, Ramin Mazaheri Nezhad Fard, Golshid Javdani Shahedin, Sedigheh Nabian
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Advanced Biomedical Research
Subjects:
angiotensin-converting enzyme 2
covid-19
glycoproteins
Online Access:http://www.advbiores.net/article.asp?issn=2277-9175;year=2022;volume=11;issue=1;spage=88;epage=88;aulast=Farhoudi

Internet

http://www.advbiores.net/article.asp?issn=2277-9175;year=2022;volume=11;issue=1;spage=88;epage=88;aulast=Farhoudi

Similar Items